| Dr Richard Edward Heywood Iii, DO | |
|
34 Bates Rd, Ste 202, Mashpee, MA 02649 | |
| (508) 681-5081 | |
| (877) 669-1746 |
| Full Name | Dr Richard Edward Heywood Iii |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 20 Years |
| Location | 34 Bates Rd, Mashpee, Massachusetts |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336118066 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0102201759 (Virginia) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 247143 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Falmouth Hospital | Falmouth, MA | Hospital |
| Cape Cod Healthcare | Hyannis, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Falmouth Women's Health Pc | 3072837384 | 3 |
News Archive
CVRx, Inc., a private medical device company, announced today it received CE Mark approval from the National Standards Authority of Ireland of the Barostim neo System for the treatment of heart failure.
Not a single person identified with autism or asperger's syndrome during a community survey in England actually knew they had the condition, research led by the University of Leicester reveals.
Researchers led by Columbia University's International Research Institute for Climate and Society and the Pan-American Health Organization have developed a system to monitor and forecast the environmental suitability of transmission of Zika, dengue fever, chikungunya and other diseases carried by species of Aedes mosquitos in the U.S. and neighboring regions.
A new study has shown that people with chronic obstructive pulmonary disease (COPD) or people with reduced lung function are at a serious risk of developing cardiovascular disease.
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
› Verified 5 days ago
| Entity Name | Saint Vincent Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013997329 PECOS PAC ID: 8921056276 Enrollment ID: O20050104000566 |
News Archive
CVRx, Inc., a private medical device company, announced today it received CE Mark approval from the National Standards Authority of Ireland of the Barostim neo System for the treatment of heart failure.
Not a single person identified with autism or asperger's syndrome during a community survey in England actually knew they had the condition, research led by the University of Leicester reveals.
Researchers led by Columbia University's International Research Institute for Climate and Society and the Pan-American Health Organization have developed a system to monitor and forecast the environmental suitability of transmission of Zika, dengue fever, chikungunya and other diseases carried by species of Aedes mosquitos in the U.S. and neighboring regions.
A new study has shown that people with chronic obstructive pulmonary disease (COPD) or people with reduced lung function are at a serious risk of developing cardiovascular disease.
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
› Verified 5 days ago
| Entity Name | Nantucket Cottage Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447214622 PECOS PAC ID: 1759357601 Enrollment ID: O20050104000928 |
News Archive
CVRx, Inc., a private medical device company, announced today it received CE Mark approval from the National Standards Authority of Ireland of the Barostim neo System for the treatment of heart failure.
Not a single person identified with autism or asperger's syndrome during a community survey in England actually knew they had the condition, research led by the University of Leicester reveals.
Researchers led by Columbia University's International Research Institute for Climate and Society and the Pan-American Health Organization have developed a system to monitor and forecast the environmental suitability of transmission of Zika, dengue fever, chikungunya and other diseases carried by species of Aedes mosquitos in the U.S. and neighboring regions.
A new study has shown that people with chronic obstructive pulmonary disease (COPD) or people with reduced lung function are at a serious risk of developing cardiovascular disease.
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
› Verified 5 days ago
| Entity Name | Nantucket Physicians Organization |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568798510 PECOS PAC ID: 6608065438 Enrollment ID: O20110111000016 |
News Archive
CVRx, Inc., a private medical device company, announced today it received CE Mark approval from the National Standards Authority of Ireland of the Barostim neo System for the treatment of heart failure.
Not a single person identified with autism or asperger's syndrome during a community survey in England actually knew they had the condition, research led by the University of Leicester reveals.
Researchers led by Columbia University's International Research Institute for Climate and Society and the Pan-American Health Organization have developed a system to monitor and forecast the environmental suitability of transmission of Zika, dengue fever, chikungunya and other diseases carried by species of Aedes mosquitos in the U.S. and neighboring regions.
A new study has shown that people with chronic obstructive pulmonary disease (COPD) or people with reduced lung function are at a serious risk of developing cardiovascular disease.
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
› Verified 5 days ago
| Entity Name | Physicians Of Falmouth Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821363698 PECOS PAC ID: 6800051970 Enrollment ID: O20120625000127 |
News Archive
CVRx, Inc., a private medical device company, announced today it received CE Mark approval from the National Standards Authority of Ireland of the Barostim neo System for the treatment of heart failure.
Not a single person identified with autism or asperger's syndrome during a community survey in England actually knew they had the condition, research led by the University of Leicester reveals.
Researchers led by Columbia University's International Research Institute for Climate and Society and the Pan-American Health Organization have developed a system to monitor and forecast the environmental suitability of transmission of Zika, dengue fever, chikungunya and other diseases carried by species of Aedes mosquitos in the U.S. and neighboring regions.
A new study has shown that people with chronic obstructive pulmonary disease (COPD) or people with reduced lung function are at a serious risk of developing cardiovascular disease.
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
› Verified 5 days ago
| Entity Name | Falmouth Women's Health Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194128355 PECOS PAC ID: 3072837384 Enrollment ID: O20150115000092 |
News Archive
CVRx, Inc., a private medical device company, announced today it received CE Mark approval from the National Standards Authority of Ireland of the Barostim neo System for the treatment of heart failure.
Not a single person identified with autism or asperger's syndrome during a community survey in England actually knew they had the condition, research led by the University of Leicester reveals.
Researchers led by Columbia University's International Research Institute for Climate and Society and the Pan-American Health Organization have developed a system to monitor and forecast the environmental suitability of transmission of Zika, dengue fever, chikungunya and other diseases carried by species of Aedes mosquitos in the U.S. and neighboring regions.
A new study has shown that people with chronic obstructive pulmonary disease (COPD) or people with reduced lung function are at a serious risk of developing cardiovascular disease.
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
› Verified 5 days ago
| Entity Name | Obhg Massachusetts Lowell Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861036451 PECOS PAC ID: 0244667574 Enrollment ID: O20200227000344 |
News Archive
CVRx, Inc., a private medical device company, announced today it received CE Mark approval from the National Standards Authority of Ireland of the Barostim neo System for the treatment of heart failure.
Not a single person identified with autism or asperger's syndrome during a community survey in England actually knew they had the condition, research led by the University of Leicester reveals.
Researchers led by Columbia University's International Research Institute for Climate and Society and the Pan-American Health Organization have developed a system to monitor and forecast the environmental suitability of transmission of Zika, dengue fever, chikungunya and other diseases carried by species of Aedes mosquitos in the U.S. and neighboring regions.
A new study has shown that people with chronic obstructive pulmonary disease (COPD) or people with reduced lung function are at a serious risk of developing cardiovascular disease.
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
› Verified 5 days ago
| Entity Name | Obhg Massachusetts - Direct Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487229035 PECOS PAC ID: 1456752609 Enrollment ID: O20210625001903 |
News Archive
CVRx, Inc., a private medical device company, announced today it received CE Mark approval from the National Standards Authority of Ireland of the Barostim neo System for the treatment of heart failure.
Not a single person identified with autism or asperger's syndrome during a community survey in England actually knew they had the condition, research led by the University of Leicester reveals.
Researchers led by Columbia University's International Research Institute for Climate and Society and the Pan-American Health Organization have developed a system to monitor and forecast the environmental suitability of transmission of Zika, dengue fever, chikungunya and other diseases carried by species of Aedes mosquitos in the U.S. and neighboring regions.
A new study has shown that people with chronic obstructive pulmonary disease (COPD) or people with reduced lung function are at a serious risk of developing cardiovascular disease.
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Edward Heywood Iii, DO 34 Bates Rd Ste 202, Mashpee, MA 02649-3280 Ph: (508) 681-5081 | Dr Richard Edward Heywood Iii, DO 34 Bates Rd, Ste 202, Mashpee, MA 02649 Ph: (508) 681-5081 |
News Archive
CVRx, Inc., a private medical device company, announced today it received CE Mark approval from the National Standards Authority of Ireland of the Barostim neo System for the treatment of heart failure.
Not a single person identified with autism or asperger's syndrome during a community survey in England actually knew they had the condition, research led by the University of Leicester reveals.
Researchers led by Columbia University's International Research Institute for Climate and Society and the Pan-American Health Organization have developed a system to monitor and forecast the environmental suitability of transmission of Zika, dengue fever, chikungunya and other diseases carried by species of Aedes mosquitos in the U.S. and neighboring regions.
A new study has shown that people with chronic obstructive pulmonary disease (COPD) or people with reduced lung function are at a serious risk of developing cardiovascular disease.
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
› Verified 5 days ago
Dr. Dale K. Weldon, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 107 Commercial Street, Community Health Center Of Cape Cod, Inc., Mashpee, MA 02649 Phone: 508-477-7090 Fax: 508-477-7028 | |
Dr. Elizabeth Marie Oshea Speed, MD Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 34 Bates Rd, Mashpee, MA 02649 Phone: 508-681-5081 Fax: 877-669-1746 | |
Robert E Prout, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 381 Great Oak Rd, #19, Mashpee, MA 02649 Phone: 508-477-5166 |